tradingkey.logo

Xtant Medical Holdings Inc

XTNT
0.591USD
+0.021+3.74%
Close 02/06, 16:00ETQuotes delayed by 15 min
82.78MMarket Cap
45.70P/E TTM

Xtant Medical Holdings Inc

0.591
+0.021+3.74%

More Details of Xtant Medical Holdings Inc Company

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Inc Info

Ticker SymbolXTNT
Company nameXtant Medical Holdings Inc
IPO dateJun 30, 2010
CEOBrowne (Sean E)
Number of employees217
Security typeOrdinary Share
Fiscal year-endJun 30
Address664 Cruiser Lane
CityBELGRADE
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code59714
Phone14063880480
Websitehttps://xtantmedical.com/
Ticker SymbolXTNT
IPO dateJun 30, 2010
CEOBrowne (Sean E)

Company Executives of Xtant Medical Holdings Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.52M
+553797.00%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
914.12K
+158228.00%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
566.93K
-8084.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
+158228.00%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.52M
+553797.00%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
914.12K
+158228.00%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
566.93K
-8084.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
+158228.00%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Orthobiologics
17.15M
51.57%
Spinal implant
10.62M
31.94%
License revenue
5.48M
16.49%
By RegionUSD
Name
Revenue
Proportion
United States
30.31M
91.15%
Rest of World
2.94M
8.85%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Orthobiologics
17.15M
51.57%
Spinal implant
10.62M
31.94%
License revenue
5.48M
16.49%

Shareholding Stats

Updated: Sat, Nov 22
Updated: Sat, Nov 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Nantahala Capital Management, LLC
48.85%
Lytton (Laurence W)
6.76%
Vizirgianakis (Stavros G)
5.37%
AWM Investment Company, Inc.
4.71%
The Vanguard Group, Inc.
1.62%
Other
32.69%
Shareholders
Shareholders
Proportion
Nantahala Capital Management, LLC
48.85%
Lytton (Laurence W)
6.76%
Vizirgianakis (Stavros G)
5.37%
AWM Investment Company, Inc.
4.71%
The Vanguard Group, Inc.
1.62%
Other
32.69%
Shareholder Types
Shareholders
Proportion
Hedge Fund
49.59%
Individual Investor
16.45%
Investment Advisor/Hedge Fund
5.20%
Investment Advisor
2.29%
Research Firm
0.04%
Other
26.42%

Institutional Shareholding

Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
41
80.10M
114.61%
--
2025Q4
60
79.99M
57.14%
-82.24M
2025Q3
58
80.07M
57.19%
-75.11M
2025Q2
66
93.42M
67.06%
-16.04M
2025Q1
66
107.33M
77.15%
-2.25M
2024Q4
65
107.45M
77.30%
-1.32M
2024Q3
60
109.08M
78.63%
+8.43M
2024Q2
61
99.68M
76.50%
-1.69M
2024Q1
63
100.56M
77.45%
+777.79K
2023Q4
59
100.17M
77.23%
+1.05M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Nantahala Capital Management, LLC
68.39M
48.85%
--
--
Sep 30, 2025
Lytton (Laurence W)
9.46M
6.76%
+9.46M
--
Apr 15, 2025
Vizirgianakis (Stavros G)
7.52M
5.37%
+553.80K
+7.95%
Nov 15, 2025
AWM Investment Company, Inc.
6.59M
4.71%
-2.50K
-0.04%
Sep 30, 2025
The Vanguard Group, Inc.
2.36M
1.68%
+104.16K
+4.63%
Sep 30, 2025
Browne (Sean E.)
1.94M
1.39%
+394.94K
+25.57%
Nov 15, 2025
Beeson (Jonn R.)
1.53M
1.09%
+158.23K
+11.51%
Nov 15, 2025
Bakewell (John K)
1.07M
0.77%
+316.46K
+41.87%
Nov 15, 2025
Renaissance Technologies LLC
713.91K
0.51%
+63.20K
+9.71%
Sep 30, 2025
Neils (Scott C)
575.01K
0.41%
+263.29K
+84.46%
Nov 15, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI